Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


10.10.2022

1 Am J Gastroenterol
2 Anticancer Res
1 BMC Cancer
5 Clin Cancer Res
3 Head Neck
1 J Nucl Med
2 J Oral Maxillofac Surg
1 Laryngoscope
3 Oral Oncol
2 Otolaryngol Head Neck Surg
1 Radiol Imaging Cancer
3 Radiother Oncol
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. KONDA V, Souza RF, Dunbar KB, Mills JC, et al
    An Endoscopic and Histologic Study on Healing of Radiofrequency Ablation Wounds in Patients With Barrett's Esophagus.
    Am J Gastroenterol. 2022;117:1583-1592.
    PubMed         Abstract available


    Anticancer Res

  2. OKADA T, Matsuki T, Fushimi C, Okamoto I, et al
    Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:4907-4912.
    PubMed         Abstract available

  3. SAKAI M, Sohda M, Uchida S, Yamaguchi A, et al
    Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) for Patients With Potentially Resectable Esophageal Cancer.
    Anticancer Res. 2022;42:4929-4935.
    PubMed         Abstract available


    BMC Cancer

  4. CUI D, Cui X, Xu X, Zhang W, et al
    Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia.
    BMC Cancer. 2022;22:1027.
    PubMed         Abstract available


    Clin Cancer Res

  5. CABANILLAS ME, Busaidy NL, Sherman SI
    Redifferentiation Therapy-Returning to Our Roots in a Post-Kinase Inhibitor World.
    Clin Cancer Res. 2022;28:4164-4166.
    PubMed         Abstract available

  6. COLEVAS AD
    HPV DNA as a Biomarker in Oropharyngeal Cancer: A Step in the Right Direction.
    Clin Cancer Res. 2022;28:4171-4172.
    PubMed         Abstract available

  7. DUKE ES, Barone AK, Chatterjee S, Mishra-Kalyani PS, et al
    FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer.
    Clin Cancer Res. 2022 Jun 9. pii: 704846. doi: 10.1158/1078-0432.CCR-22-0873.
    PubMed         Abstract available

  8. WEBER M, Kersting D, Riemann B, Brandenburg T, et al
    Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancer With MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study.
    Clin Cancer Res. 2022 May 20. pii: 699089. doi: 10.1158/1078-0432.CCR-22-0437.
    PubMed         Abstract available

  9. BERGER BM, Hanna GJ, Posner MR, Genden EM, et al
    Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma.
    Clin Cancer Res. 2022;28:4292-4301.
    PubMed         Abstract available


    Head Neck

  10. HE Y, Li H, Wang K, Wang J, et al
    Fourteen years old as the best age cutoff to differentiate prepubertal from pubertal papillary thyroid carcinoma.
    Head Neck. 2022 Oct 6. doi: 10.1002/hed.27208.
    PubMed         Abstract available

  11. MAZUL AL, Chidambaram S, Zevallos JP, Massa ST, et al
    Disparities in head and neck cancer incidence and trends by race/ethnicity and sex.
    Head Neck. 2022 Oct 6. doi: 10.1002/hed.27209.
    PubMed         Abstract available

  12. SCHLAFSTEIN AJ, Goyal S, Amini A, Karam SD, et al
    The impact of operability status on outcomes in patients with T4 larynx cancer undergoing larynx preservation.
    Head Neck. 2022 Oct 5. doi: 10.1002/hed.27204.
    PubMed         Abstract available


    J Nucl Med

  13. SIGNORE A, Campagna G, Marinaccio J, de Vitis M, et al
    Analysis of short term and stable DNA damage in patients with differentiated thyroid cancer treated with (131)I in hypothyroidism or with rhTSH for remnant ablation.
    J Nucl Med. 2022 Feb 3. pii: jnumed.121.263442. doi: 10.2967/jnumed.121.263442.
    PubMed         Abstract available


    J Oral Maxillofac Surg

  14. KUMAR A, Ghai S
    RE: Does Total Parotidectomy Improve Survival Over Partial Parotidectomy in Early Stage Adenoid Cystic Carcinoma of the Parotid Gland?
    J Oral Maxillofac Surg. 2022;80:1577.
    PubMed        

  15. LEE KC, Chuang SK
    Reply: Does Total Parotidectomy Improve Survival Over Partial Parotidectomy in Early Stage Adenoid Cystic Carcinoma of the Parotid Gland?
    J Oral Maxillofac Surg. 2022;80:1577-1578.
    PubMed        


    Laryngoscope

  16. WU HY, Shan XF, Cai ZG, Zhang J, et al
    Timing of Oral Feeding in Patients Who have Undergone Free Flap Reconstruction for Oral Cancer.
    Laryngoscope. 2022 Oct 6. doi: 10.1002/lary.30435.
    PubMed         Abstract available


    Oral Oncol

  17. LIU W, Ji T, Zhang C, Zhou Q, et al
    Cell-free DNA hypermethylated genes may have a limited role in cancer screening but a potential role in risk assessment of head and neck cancer.
    Oral Oncol. 2022;134:106129.
    PubMed         Abstract available

  18. HENG Y, Yang Z, Lin J, Liu Q, et al
    Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis.
    Oral Oncol. 2022;134:106185.
    PubMed         Abstract available

  19. ZHU GL, Fang XL, Yang KB, Tang LL, et al
    Development and validation of a joint model for dynamic prediction of overall survival in nasopharyngeal carcinoma based on longitudinal post-treatment plasma cell-free Epstein-Barr virus DNA load.
    Oral Oncol. 2022;134:106140.
    PubMed         Abstract available


    Otolaryngol Head Neck Surg

  20. WIESER ME, Sagalow ES, Givens A, Curry JM, et al
    Occult Metastases During Salvage Oral Cavity and Oropharyngeal Free Flaps: Oncologic Outcomes.
    Otolaryngol Head Neck Surg. 2022;167:645-649.
    PubMed         Abstract available

  21. COHEN ER, Misztal C, Dable C, Gomez-Fernandez C, et al
    Redefining Perineural Invasion in Head and Neck Cutaneous Squamous Cell Carcinoma.
    Otolaryngol Head Neck Surg. 2022;167:705-715.
    PubMed         Abstract available


    Radiol Imaging Cancer

  22. BAUMGARTEN DA
    O-RADS: Good Enough for Everyday Practice or a Work in Progress?
    Radiol Imaging Cancer. 2022;4:e220121.
    PubMed        


    Radiother Oncol

  23. TOPKAN E, Somay E, Yilmaz B
    In regard to recent published study of Massaccesi et al. titled 'A predictive nomogram for trismus after radiotherapy for head and neck cancer'. (Radiother Oncol. 2022 Jun 2: S0167-8140(22)04137-8. doi: 10.1016/j.radonc.2022.05.031).
    Radiother Oncol. 2022;174:132.
    PubMed        

  24. KOO J, Caudell JJ, Latifi K, Jordan P, et al
    Comparative evaluation of a prototype deep learning algorithm for autosegmentation of normal tissues in head and neck radiotherapy.
    Radiother Oncol. 2022;174:52-58.
    PubMed         Abstract available

  25. NADERI E, Schack LMH, Welsh C, Sim AYL, et al
    Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer.
    Radiother Oncol. 2022 Sep 30. pii: S0167-8140(22)04486.
    PubMed         Abstract available


    Thyroid

  26. SASAKI T, Miyauchi A, Fujishima M, Ito Y, et al
    Comparison of postoperative unfavorable events in patients with low-risk papillary thyroid carcinoma: Immediate surgery vs. conversion surgery following active surveillance.
    Thyroid. 2022 Oct 7. doi: 10.1089/thy.2022.0444.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: